Tianjin Tianyao Pharmaceuticals Co., Ltd.SSE: 600488

2025 Semi-annual Report

Aug 23, 2025 · Issued by Tianjin Tianyao Pharmaceuticals Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Aug 23, 2025

On 6ix: 6ix.com/news/2025-semi-annual-report-54

2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Tianjin Tianyao Pharmaceuticals Co., Ltd. on 6ix

Earlier from Tianjin Tianyao Pharmaceuticals

Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025Aug 13, 2025
Announcement on Change of Drug Production LicenseAug 9, 2025
Announcement on Receiving Results of GMP Compliance Inspection Concerning DrugsAug 1, 2025
Announcement on Resolutions of the 19th Meeting of the 9th Board of DirectorsJul 26, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025Jul 16, 2025

Later from Tianjin Tianyao Pharmaceuticals

Announcement on the Company's Receipt of the Notice of Approval for Marketing Application of Chemical APIsAug 30, 2025
Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Tianjin JurisdictionSep 12, 2025
Announcement on Convening the Q3 2025 Performance BriefingOct 29, 2025
Announcement on Subsidiary’s Products Being Proposed for Selection in the National Centralized Drug ProcurementOct 30, 2025
Announcement on Outline of the Q3 2025 Performance BriefingNov 20, 2025

All Tianjin Tianyao Pharmaceuticals news releases

Follow Tianjin Tianyao Pharmaceuticals into a list and get an email when it puts out news.

Follow Tianjin Tianyao Pharmaceuticals